# Mirum Pharmaceuticals, Inc.: filings

MIRM · Nasdaq · CIK 1759425 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mirm.md) · [Financials](/companies/mirm/financials.md) · [Filings](/companies/mirm/filings.md) · [Insiders](/companies/mirm/insiders.md)

## Reports and events: 149 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 313, 8-K 85, 144 55, 3 38, 10-Q 22, SC 13G/A 16, SCHEDULE 13G/A 16, SC 13D/A 15, S-8 10, CORRESP 9, SC 13G 9, 10-K 7, DEF 14A 7, DEFA14A 7, UPLOAD 7, 424B5 5, ARS 4, EFFECT 4, S-3ASR 4, SC 13D 4, D 3, SCHEDULE 13D/A 3, 424B4 2, 4/A 2, 8-K/A 2, DRS 2, S-1 2, S-1/A 2, S-3 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, DRS/A 1, DRSLTR 1, NT 10-K 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:47 ET | [8-K](/filings/0001759425-26-000054.md) | 8.01 Other events | 0001759425-26-000054 |
| 2026-10-13 | 08:09 ET | [8-K](/filings/0001759425-26-000051.md) | 8.01 Other events | 0001759425-26-000051 |
| 2026-09-28 | 08:02 ET | [8-K](/filings/0001759425-26-000049.md) | 8.01 Other events | 0001759425-26-000049 |
| 2026-09-08 | 08:34 ET | [8-K](/filings/0001759425-26-000047.md) | 5.02 Departure or appointment of officers or directors | 0001759425-26-000047 |
| 2026-08-05 | 16:06 ET | [10-Q](/filings/0001759425-26-000045.md) | Quarterly report, period 2026-06-30 | 0001759425-26-000045 |
| 2026-08-05 | 16:02 ET | [8-K](/filings/0001759425-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-26-000044 |
| 2026-06-18 | 16:05 ET | [8-K](/filings/0001193125-26-275811.md) | 5.07 Shareholder vote results | 0001193125-26-275811 |
| 2026-05-18 | 16:06 ET | [8-K](/filings/0001193125-26-228902.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-228902 |
| 2026-05-06 | 16:07 ET | [10-Q](/filings/0001759425-26-000037.md) | Quarterly report, period 2026-03-31 | 0001759425-26-000037 |
| 2026-05-06 | 16:04 ET | [8-K](/filings/0001759425-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-26-000036 |
| 2026-05-04 | 08:00 ET | [8-K](/filings/0001193125-26-202609.md) | 8.01 Other events | 0001193125-26-202609 |
| 2026-04-27 | 08:07 ET | [8-K](/filings/0001193125-26-179048.md) | 8.01 Other events | 0001193125-26-179048 |
| 2026-04-23 | 16:39 ET | [DEF 14A](/filings/0001759425-26-000027.md) | Proxy statement, period 2025-12-31 | 0001759425-26-000027 |
| 2026-04-08 | 16:13 ET | [8-K/A](/filings/0001759425-26-000021.md) | 9.01 Financial statements and exhibits | 0001759425-26-000021 |
| 2026-02-25 | 16:28 ET | [10-K](/filings/0001759425-26-000013.md) | Annual report, period 2025-12-31 | 0001759425-26-000013 |
| 2026-02-25 | 16:03 ET | [8-K](/filings/0001759425-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-26-000010 |
| 2026-01-27 | 16:12 ET | [SCHEDULE 13D/A](/filings/0001231919-26-000093.md) | Ownership report, active investor, amended | 0001231919-26-000093 |
| 2026-01-26 | 16:10 ET | [8-K](/filings/0001193125-26-022582.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-022582 |
| 2026-01-12 | 08:40 ET | [8-K](/filings/0001759425-26-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759425-26-000004 |
| 2025-12-19 | 16:06 ET | [8-K](/filings/0001193125-25-326822.md) | 8.01 Other events | 0001193125-25-326822 |
| 2025-12-19 | 08:30 ET | [8-K](/filings/0001193125-25-325825.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-325825 |
| 2025-12-08 | 08:00 ET | [8-K](/filings/0001193125-25-310611.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310611 |
| 2025-11-17 | 16:52 ET | [8-K](/filings/0001759425-25-000057.md) | 8.01 Other events | 0001759425-25-000057 |
| 2025-11-04 | 17:26 ET | [SCHEDULE 13D/A](/filings/0001231919-25-000420.md) | Ownership report, active investor, amended | 0001231919-25-000420 |
| 2025-11-04 | 16:05 ET | [10-Q](/filings/0001759425-25-000054.md) | Quarterly report, period 2025-09-30 | 0001759425-25-000054 |
| 2025-11-04 | 16:02 ET | [8-K](/filings/0001759425-25-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-25-000053 |
| 2025-08-20 | 17:17 ET | [SCHEDULE 13D/A](/filings/0001415889-25-022494.md) | Ownership report, active investor, amended | 0001415889-25-022494 |
| 2025-08-06 | 16:06 ET | [10-Q](/filings/0001759425-25-000041.md) | Quarterly report, period 2025-06-30 | 0001759425-25-000041 |
| 2025-08-06 | 16:03 ET | [8-K](/filings/0001759425-25-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-25-000040 |
| 2025-05-30 | 16:35 ET | [8-K](/filings/0001759425-25-000034.md) | 5.07 Shareholder vote results | 0001759425-25-000034 |
| 2025-05-07 | 16:08 ET | [10-Q](/filings/0001759425-25-000032.md) | Quarterly report, period 2025-03-31 | 0001759425-25-000032 |
| 2025-05-07 | 16:02 ET | [8-K](/filings/0001759425-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-25-000030 |
| 2025-04-14 | 16:06 ET | [DEF 14A](/filings/0001759425-25-000022.md) | Proxy statement, period 2025-04-14 | 0001759425-25-000022 |
| 2025-02-26 | 16:09 ET | [10-K](/filings/0001759425-25-000014.md) | Annual report, period 2024-12-31 | 0001759425-25-000014 |
| 2025-02-26 | 16:06 ET | [8-K](/filings/0001759425-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-25-000012 |
| 2025-01-13 | 08:32 ET | [8-K](/filings/0001759425-25-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759425-25-000003 |
| 2024-11-12 | 08:14 ET | [10-Q](/filings/0001759425-24-000038.md) | Quarterly report, period 2024-09-30 | 0001759425-24-000038 |
| 2024-11-12 | 08:04 ET | [8-K](/filings/0001759425-24-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-24-000037 |
| 2024-08-07 | 16:11 ET | [10-Q](/filings/0001759425-24-000031.md) | Quarterly report, period 2024-06-30 | 0001759425-24-000031 |
| 2024-08-07 | 16:06 ET | [8-K](/filings/0001759425-24-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-24-000029 |
| 2024-06-17 | 08:03 ET | [8-K](/filings/0001193125-24-162056.md) | 8.01 Other events | 0001193125-24-162056 |
| 2024-06-06 | 16:38 ET | [8-K](/filings/0001759425-24-000023.md) | 5.07 Shareholder vote results | 0001759425-24-000023 |
| 2024-05-31 | 17:24 ET | [8-K](/filings/0001193125-24-151965.md) | 8.01 Other events | 0001193125-24-151965 |
| 2024-05-08 | 16:16 ET | [10-Q](/filings/0001759425-24-000019.md) | Quarterly report, period 2024-03-31 | 0001759425-24-000019 |
| 2024-05-08 | 16:04 ET | [8-K](/filings/0001759425-24-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-24-000017 |
| 2024-04-23 | 16:20 ET | [DEF 14A](/filings/0001759425-24-000011.md) | Proxy statement, period 2024-04-23 | 0001759425-24-000011 |
| 2024-03-15 | 17:03 ET | [10-K](/filings/0000950170-24-032289.md) | Annual report, period 2023-12-31 | 0000950170-24-032289 |
| 2024-02-28 | 16:05 ET | [8-K](/filings/0001759425-24-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759425-24-000005 |
| 2024-01-16 | 16:15 ET | [8-K](/filings/0001193125-24-008569.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-008569 |
| 2024-01-08 | 08:30 ET | [8-K](/filings/0001193125-24-003965.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003965 |

Page 1 of 3. [Older](/companies/mirm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:48 ET. No prices; not investment advice.